Koninklijke Philips N.V
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral… Read more
Market Cap & Net Worth: Koninklijke Philips N.V (RYLPF)
Koninklijke Philips N.V (PINK:RYLPF) has a market capitalization of $20.89 Billion ($20.89 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #933 globally and #726 in its home market, demonstrating a -13.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Koninklijke Philips N.V's stock price $21.96 by its total outstanding shares 951289000 (951.29 Million).
Koninklijke Philips N.V Market Cap History: 2015 to 2025
Koninklijke Philips N.V's market capitalization history from 2015 to 2025. Data shows growth from $19.72 Billion to $20.89 Billion (0.54% CAGR).
Koninklijke Philips N.V Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Koninklijke Philips N.V's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.44x
Koninklijke Philips N.V's market cap is 1.44 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $19.72 Billion | $24.24 Billion | $645.00 Million | 0.81x | 30.57x |
| 2016 | $24.13 Billion | $24.52 Billion | $1.45 Billion | 0.98x | 16.67x |
| 2017 | $30.62 Billion | $17.78 Billion | $1.66 Billion | 1.72x | 18.48x |
| 2018 | $29.08 Billion | $18.12 Billion | $1.09 Billion | 1.60x | 26.68x |
| 2019 | $41.47 Billion | $19.48 Billion | $1.17 Billion | 2.13x | 35.50x |
| 2020 | $49.08 Billion | $19.54 Billion | $1.19 Billion | 2.51x | 41.35x |
| 2021 | $34.04 Billion | $17.16 Billion | $3.32 Billion | 1.98x | 10.26x |
| 2022 | $13.56 Billion | $17.83 Billion | -$1.61 Billion | 0.76x | N/A |
| 2023 | $22.12 Billion | $18.17 Billion | -$466.00 Million | 1.22x | N/A |
| 2024 | $25.89 Billion | $18.02 Billion | -$702.00 Million | 1.44x | N/A |
Competitor Companies of RYLPF by Market Capitalization
Companies near Koninklijke Philips N.V in the global market cap rankings as of March 18, 2026.
Key companies related to Koninklijke Philips N.V by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Koninklijke Philips N.V Historical Marketcap From 2015 to 2025
Between 2015 and today, Koninklijke Philips N.V's market cap moved from $19.72 Billion to $ 20.89 Billion, with a yearly change of 0.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $20.89 Billion | -19.32% |
| 2024 | $25.89 Billion | +17.07% |
| 2023 | $22.12 Billion | +63.10% |
| 2022 | $13.56 Billion | -60.16% |
| 2021 | $34.04 Billion | -30.65% |
| 2020 | $49.08 Billion | +18.35% |
| 2019 | $41.47 Billion | +42.58% |
| 2018 | $29.08 Billion | -5.01% |
| 2017 | $30.62 Billion | +26.88% |
| 2016 | $24.13 Billion | +22.38% |
| 2015 | $19.72 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Koninklijke Philips N.V was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.89 Billion USD |
| MoneyControl | $20.89 Billion USD |
| MarketWatch | $20.89 Billion USD |
| marketcap.company | $20.89 Billion USD |
| Reuters | $20.89 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.